BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 18181711)

  • 1. Clinical research on probiotics: the interface between science and regulation.
    Tamayo C
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S101-3; discussion S144-51. PubMed ID: 18181711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safe and efficacious probiotics: what are they?
    Reid G
    Trends Microbiol; 2006 Aug; 14(8):348-52. PubMed ID: 16809039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics in the United States.
    Vanderhoof JA; Young R
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S67-72; discussion S144-51. PubMed ID: 18181726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-benefit claims for probiotic products.
    Heimbach JT
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S122-4; discussion S144-51. PubMed ID: 18181716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of probiotics as biologic drugs.
    Hoffman FA
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S125-7; discussion S144-51. PubMed ID: 18181717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of probiotic substances as ingredients in foods: premarket approval or "generally recognized as safe" notification.
    Mattia A; Merker R
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S115-8; discussion S144-51. PubMed ID: 18181714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotic foods and drugs: impact of US regulatory status on design of clinical trials.
    Hibberd PL; Davidson L
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S137-40; discussion S144-51. PubMed ID: 18181720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical testing in the development of probiotics: a regulatory perspective with Bacillus strains as an example.
    Sorokulova I
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S92-5; discussion S144-51. PubMed ID: 18181731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of probiotics.
    Donohue DC
    Asia Pac J Clin Nutr; 2006; 15(4):563-9. PubMed ID: 17077077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. US Food and Drug Administration regulations governing label claims for food products, including probiotics.
    Saldanha LG
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S119-21; discussion S144-51. PubMed ID: 18181715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The US Food and Drug Administration and probiotics: regulatory categorization.
    Degnan FH
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S133-6; discussion S144-51. PubMed ID: 18181719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics and European Food Safety Authority health claims.
    Capurso L; Morelli L
    J Clin Gastroenterol; 2010 Sep; 44 Suppl 1():S1. PubMed ID: 20716983
    [No Abstract]   [Full Text] [Related]  

  • 13. [Assessment of probiotics according to the international organizations (FAO/WHO)].
    Liaskovskiĭ TM; Podgorskiĭ VS
    Mikrobiol Z; 2005; 67(6):104-12. PubMed ID: 16493892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Questions linger over European GM food regulations.
    Ramón D; MacCabe A; Gil JV
    Nat Biotechnol; 2004 Feb; 22(2):149. PubMed ID: 14755281
    [No Abstract]   [Full Text] [Related]  

  • 15. Probiotics: time for a dose of realism.
    Tannock GW
    Curr Issues Intest Microbiol; 2003 Sep; 4(2):33-42. PubMed ID: 14503687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergen-free probiotics.
    Mogna G; Strozzi GP; Mogna L
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S201-4. PubMed ID: 18685500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Probiotic Conundrum: Regulatory Confusion, Conflicting Studies, and Safety Concerns.
    Freedman SB; Schnadower D; Tarr PI
    JAMA; 2020 Mar; 323(9):823-824. PubMed ID: 32125410
    [No Abstract]   [Full Text] [Related]  

  • 18. Current marketplace for probiotics: a Japanese perspective.
    Amagase H
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S73-5; discussion S144-51. PubMed ID: 18181727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety of probiotics.
    Snydman DR
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S104-11; discussion S144-51. PubMed ID: 18181712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Executive summary: scientific and regulatory challenges of development of probiotics as foods and drugs.
    Hoffman FA; Heimbach JT; Sanders ME; Hibberd PL
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S53-7. PubMed ID: 18181723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.